Literature DB >> 33682607

lncRNA SNHG14 promotes oncogenesis and immune evasion in diffuse large-B-cell lymphoma by sequestering miR-152-3p.

Yuyang Tian1, Lianqiao Li1, Guoqiang Lin2, Yan Wang1, Li Wang2, Qian Zhao2, Youdong Hu2, Hongmei Yong2, Yan Wan2, Yanming Zhang2.   

Abstract

This study aimed to explore the role of small nucleolar RNA host gene 14 (SNHG14) in the pathogenesis of diffuse large-B-cell lymphoma (DLBCL). DLBCL cell lines (OCI-Ly7 and OCI-Ly3) and specimens from patients were collected to evaluate the roles of SNHG14 in DLBCL pathogenesis. The results showed that SNHG14 expression increased and miR-152-3p expression decreased in DLBCL tissues and cell lines, indicating a negative correlation between miR-152-3p and SNHG14 expression. Moreover, SNHG14 was found to promote DLBCL growth, migration, and EMT-like processes in vitro, and directly inhibits miR-152-3p gene expression via sequestration of the miR-152-3p transcripts in DLBCL. Additionally, SNHG14/miR-152-3p inhibits apoptosis and promotes cell proliferation on cytotoxic T lymphocytes (CTLs) in DLBCL via the PD-1/PD-L1 checkpoint. Furthermore, both the immune escape and progression of DLBCL are advanced by SNHG14 expression via its interactions with miR-152-3p. Collective, this suggests that SNHG14 is a potential diagnostic, prognostic, and therapeutic target for DLBCL.

Entities:  

Keywords:  Diffuse large B cell lymphoma (DLBCL); LncRNA SNHG14; MiR-152-3p; PD-L1; immune evasion

Mesh:

Substances:

Year:  2021        PMID: 33682607     DOI: 10.1080/10428194.2021.1876866

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  8 in total

1.  N 6 -Methyladenosine-Related Long Non-Coding RNAs Are Identified as a Potential Prognostic Biomarker for Lung Squamous Cell Carcinoma and Validated by Real-Time PCR.

Authors:  Wei Zhang; Qian Zhang; Zhefan Xie; Li Che; Tingting Xia; Xingdong Cai; Shengming Liu
Journal:  Front Genet       Date:  2022-06-03       Impact factor: 4.772

Review 2.  Regulation of temozolomide resistance via lncRNAs: Clinical and biological properties of lncRNAs in gliomas (Review).

Authors:  Sui Li; Xiaofang Xie; Fu Peng; Junrong Du; Cheng Peng
Journal:  Int J Oncol       Date:  2022-07-07       Impact factor: 5.884

3.  Long non-coding RNA (LncRNA) CHROMR promotes the expression of the CNNM1 gene by adsorbing hsa-miR-1299 to obtain drug resistance in diffuse large B lymphoma cells.

Authors:  Mingyue Wang; Zhichao Miao; Hong Cen; Jiaxu He; Changyuan Wei
Journal:  Transl Cancer Res       Date:  2022-05       Impact factor: 0.496

4.  The genomic and transcriptional landscape of primary central nervous system lymphoma.

Authors:  Josefine Radke; Naveed Ishaque; Randi Koll; Zuguang Gu; Elisa Schumann; Lina Sieverling; Sebastian Uhrig; Daniel Hübschmann; Umut H Toprak; Cristina López; Xavier Pastor Hostench; Simone Borgoni; Dilafruz Juraeva; Fabienne Pritsch; Nagarajan Paramasivam; Gnana Prakash Balasubramanian; Matthias Schlesner; Shashwat Sahay; Marc Weniger; Debora Pehl; Helena Radbruch; Anja Osterloh; Agnieszka Korfel; Martin Misch; Julia Onken; Katharina Faust; Peter Vajkoczy; Dag Moskopp; Yawen Wang; Andreas Jödicke; Lorenz Trümper; Ioannis Anagnostopoulos; Dido Lenze; Ralf Küppers; Michael Hummel; Clemens A Schmitt; Otmar D Wiestler; Stephan Wolf; Andreas Unterberg; Roland Eils; Christel Herold-Mende; Benedikt Brors; Reiner Siebert; Stefan Wiemann; Frank L Heppner
Journal:  Nat Commun       Date:  2022-05-10       Impact factor: 17.694

Review 5.  The emerging role non-coding RNAs in B cell-related disorders.

Authors:  Soudeh Ghafouri-Fard; Tayyebeh Khoshbakht; Bashdar Mahmud Hussen; Mohammad Taheri; Elena Jamali
Journal:  Cancer Cell Int       Date:  2022-02-22       Impact factor: 5.722

6.  miR-152-3p impedes the malignant phenotypes of hepatocellular carcinoma by repressing roundabout guidance receptor 1.

Authors:  Tao Yin; Haonan Zhao
Journal:  Cell Mol Biol Lett       Date:  2022-03-02       Impact factor: 5.787

Review 7.  Small but strong: Pivotal roles and potential applications of snoRNAs in hematopoietic malignancies.

Authors:  Jian Dong; Hui Wang; Zhaoru Zhang; Lin Yang; Xinyue Qian; Wenchang Qian; Yingli Han; He Huang; Pengxu Qian
Journal:  Front Oncol       Date:  2022-08-12       Impact factor: 5.738

Review 8.  Competitive Endogenous RNA Network Involving miRNA and lncRNA in Non-Hodgkin Lymphoma: Current Advances and Clinical Perspectives.

Authors:  Mara Fernandes; Herlander Marques; Ana Luísa Teixeira; Rui Medeiros
Journal:  Biomedicines       Date:  2021-12-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.